Pulse Biosciences, Inc.
Pulse Biosciences, Inc. (PLSE) has a dated narrative snapshot, but its priced-in model claim is temporarily suppressed because the model-solve record is unavailable or has changed.
89 institutional managers reported holding PLSE in 13F filings for the quarter ended 2026-03-31. Together they hold about 11% of the company; the top 10 hold 9%. 26 opened new positions that quarter. Held by BlackRock, Vanguard Group, Geode Capital, among others. On the short side, 2.8M shares were sold short as of the 2026-06-15 count, about 4% of shares outstanding (8.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
PLSE's share count grew 156.8% over the past five years. It pays no dividend.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at PLSE over the trailing three years: 2023: 28 buys totaling $9.69M; 2024: 7 buys totaling $5.07M; 2025: 1 buy totaling $508k. 6 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
PLSE's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-11 | -0.4% | -43.8% |
| 2023-11-14 | +12.8% | +41.4% |
| 2024-03-29 | +3.7% | +32.6% |
| 2024-05-08 | -10.7% | +115.4% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
PLSE's latest 8-K filings: 2026-08-06 (items 1.01, 9.01); 2026-08-06 (items 2.02, 9.01); 2026-07-29 (items 8.01, 9.01); 2026-06-12 (items 5.07); 2026-06-10 (items 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 28, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.